Stephen K. Brannan, Chief Medical Officer at Karuna Therapeutics, Inc. (KRTX), sold 9,735 shares at $174.11 ($1.7M) on 2023-11-08, disclosed to the SEC on 2023-11-13.
Scheduled sale ($1.7M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $174.11 | 1,281 | $223K | 12.9% |
| 2 | $174.11 | 1,281 | $223K | 12.9% |
| 3 | $175.69 | 401 | $70K | 4.1% |
| 4 | $175.69 | 401 | $70K | 4.1% |
| 5 | $177.14 | 265 | $47K | 2.7% |
| 6 | $178.90 | 808 |
| $145K |
| 8.3% |
| 7 | $178.90 | 808 | $145K | 8.3% |
| 8 | $180.08 | 2,245 | $404K | 23.3% |
| 9 | $180.08 | 2,245 | $404K | 23.3% |
| Total | $177.87 avg | 9,735 | $1.7M | 100% |
| Filing → |
| KRTX | SELL | 2024-02-12 | $3.2M | — | Filing → |
| KRTX | SELL | 2024-01-09 | $4.8M | — | Filing → |
| KRTX | SELL | 2023-12-12 | $4.0M | — | Filing → |